candycrushsodasagafreedownload| Kodi-B (02487.HK): The world's first new drug for topical treatment of hair loss submitted to the Hong Kong Department of Health for marketing application-Fitness-balckjack

Newsletter summary

Kodi-B (02487)Candycrushsodasagafreedownload. HK) Application for the listing of CU-40102 new drugs has been submitted to the Department of Health of Hong KongCandycrushsodasagafreedownloadThis is the world's first finasteride spray for topical use in the treatment of androgenic hair loss.

candycrushsodasagafreedownload| Kodi-B (02487.HK): The world's first new drug for topical treatment of hair loss submitted to the Hong Kong Department of Health for marketing application

Text of news flash

[April 30Candycrushsodasagafreedownload, Kodi-B (02487CandycrushsodasagafreedownloadHK) submitted an application (NDA) for its new drug CU-40102 (finasteride spray for topical use) to the Hong Kong Department of Health for the treatment of androgenic hair loss. ]

CU-40102 is the world's first and only finasteride product approved for the treatment of androgenic alopecia, according to the Cordi-B announcement. Previously, the drug was accepted by the NDA of China's State Drug Administration (NMPA) in January 2024.

Finasteride, as a specific type II 5-reductase competition inhibitor, can effectively inhibit the conversion of testosterone to dihydrotestosterone in the scalp, thus treating androgenic alopecia in men. Compared with traditional oral finasteride, the topical form of CU-40102 is convenient for patients to accurately apply to the affected area, increase the drug concentration, and reduce the side effects of oral drugs.